The Subject Expert Committee of India's Apex Drugs Authority Drugs Controller General of ... - Latest Tweet by IANS India
The latest Tweet by IANS India states, 'The Subject Expert Committee of India's apex drugs authority Drugs Controller General of India has recommended permission for vaccine manufacturer @SerumInstIndia to conducting Phase 3 trial of #Covovax as booster dose in adults, said a source familiar with the development.'
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)